Posts

New PBS listings for gastro-intestinal cancer patients help combat ‘financial toxicity’ of treatment

Gastro-intestinal cancer patients with advanced colorectal cancer and neuroendocrine tumours will benefit as part of five new cancer listings added to the Pharmaceutical Benefits Scheme (PBS) on 1 December.